PITTSBURGH – The No. 1 seeded Pitt volleyball team (29-4, 18-2 ACC) will play No. 3 seed Purdue (27-6, 15-5 Big Ten) for a chance to advance to its fifth consecutive National Semifinal on Saturday night at 7:30 p.m. at the Petersen Events…
Author: admin
-

Cougars Visit Trojans Sunday Afternoon
WASHINGTON STATE COUGARS (3-7, 0-0 WCC) at SOUTHERN CALIFORNIA TROJANS (9-1, 1-1 B1G)
SUNDAY, DECEMBER 14, 2025
4:35 p.m. PT
Los…Continue Reading
-

Trump demands Fed listen to him as he lines up new leader: ‘I’m a smart voice’ | Federal Reserve
Donald Trump declared he “should be listened to” by the Federal Reserve, as he weighs candidates to lead the central bank amid an extraordinary campaign by the White House to exert greater control over its decisions.
The US president said on Friday that former Fed governor Kevin Warsh is currently top of his list to chair the central bank.
Jerome Powell, the current Fed chairperson, is scheduled to finish an eight-year stint in the role next May. He has repeatedly defied Trump’s demands for drastic cuts to interest rates, prompting the president to launch a string of public attacks.
Trump is also considering his adviser Kevin Hassett, who leads the National Economic Council, as a potential chair of the Fed.
“I think you have Kevin and Kevin. They’re both – I think the two Kevins are great,” the president told the Wall Street Journal on Friday. “I think there are a couple of other people that are great.”
He is expected to soon nominate a candidate to lead the Fed, having lambasted the central bank’s policymakers for their cautious approach to cutting rates since return to office in January – and has even tried to fire a member of the central bank’s rate-setting policy committee.
Warsh “thinks you have to lower interest rates,” Trump claimed in the interview, in line with the views he has expressed himself for months. “And so does everybody else that I’ve talked to.”
Trump argued that the next Fed chair should listen to him on the future direction of rates. “Typically, that’s not done anymore,” he acknowledged to the Wall Street Journal. “It should be done.”
“It doesn’t mean – I don’t think he should do exactly what we say,” Trump added. “But certainly we’re – I’m a smart voice and should be listened to.”
Earlier this week, the Fed cut rates by a quarter point for the third time this year. But policymakers signaled their reluctance to cut more than once next year, amid heightened uncertainty around the direction of the economy.
In a press conference on Wednesday, Powell said the Fed was trying to balance “significant downside risks” in the jobs market with inflationary pressures from Trump’s tariffs that are “pretty clear to see”.
Continue Reading
-
Maryland researchers’ system could wipe out cervical cancer worldwide – Baltimore Sun
- Maryland researchers’ system could wipe out cervical cancer worldwide Baltimore Sun
- Karen Canfell: A Historic Milestone in Cervical Cancer Elimination in Australia Oncodaily
- Vaccinating Boys Could Help Eliminate Cervical Cancer Technology…
Continue Reading
-

Teva Pharmaceutical Industries Ltd. – Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025 financial results on Wednesday, January 28, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.
In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations.
Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This Document and the presentation at the conferences may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the section captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Teva Media Inquiries
[email protected]Teva Investor Relations Inquiries
[email protected]
Continue Reading
-

Orion Safety Products Announces Recall of Select Flare Models
The Louisiana Department of Wildlife and Fisheries Enforcement Division is alerting the boating public about a flare safety recall.
Orion Safety Products, the manufacturer of the hand-launched Skyblazer II Red XLT Aerial Signals (“XLTs”) flare received a report indicating that an XLT ignited without the safety cap being removed or the ignition cord being pulled. The report and photographs indicate that the flare did not launch but burned in place.
As Orion continues to investigate, this recall and product quarantine encompasses all XLT products with the following revised impacted Orion product numbers and expiration dates: Product Numbers 769, 855/855A, and 859, with expiration dates of August 2028 through April 2029. Orion is advising all owners of these flares to immediately stop using them and to store them in a safe and secure location away from combustible products until further notice.
Orion has posted instructions for its recommended procedure to quarantine impacted XLTs on its website at https://www.orionsignals.com/project/recall-notices/.
Orion is currently conducting an exhaustive investigation as to the cause of the reported incident. Once more information is known, Orion will provide more information on how they will collect and destroy the recalled flares and when a replacement product will be provided.
Orion has notified the U.S. Coast Guard and the Consumer Product Safety Commission of this occurrence.
URGENT SAFETY RECALL AND PRODUCT QUARANTINE
Skyblazer II Red XLT Aerial Signals
Updated November 26, 2025
Incidence Report. Orion Safety Products, the manufacturer of the hand-launched Skyblazer II Red XLT Aerial Signals (“XLTs”) received a report indicating that an XLT ignited without the safety cap being removed or the ignition cord being pulled. The report and photographs indicate that the flare did not launch but burned in place. There were no reported injuries.Impacted XLTs. As Orion continues to investigate, this recall and product quarantine encompasses all XLT products with the below REVISED impacted Orion product numbers and Expiration Dates:
Product Numbers 769, 855/855A and 859 with an Expiration Date of August 2028 through April 2029
Quarantine. As the investigation continues, Orion is directing all customers, distributors, dealers and consumers to:
Immediately stop using all XLT signals with the Expiration Dates noted in Section B above.
Quarantine all impacted XLTs and store the product in a safe and secure location away from combustible products until further notice.Orion has posted instructions for its recommended procedure to quarantine impacted XLTs on its website at https://www.orionsignals.com/project/recall-notices/.
Next Steps. Orion is currently conducting an exhaustive investigation as to the cause of the reported incident. Once more information is known, Orion will contact you to provide more information, including:
How Orion will arrange for collection/destruction of quarantined product
How and when replacement product will be providedAs more information becomes available Orion will post updates on its website.
Orion is critically concerned about the safety of our customers. We are notifying the U.S. Coast Guard and the Consumer Product Safety Commission of this occurrence. It is imperative you segregate and secure any XLTs that are identified in Section B above as soon as possible. We understand that this is a complex issue and we thank you in advance for your patience and understanding while we continue to investigate this matter and the logistics for moving forward.
Continue Reading
-

Creating connection and elevating belonging: DII Super Region Convention highlights student-athlete impact
November’s Division II Student-Athlete Advisory Committee Super Region Convention was designed to center…
Continue Reading
-

Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
COVID-19 rates in the United States and Europe remain low, but influenza and respiratory syncytial virus (RSV) activity is ramping up in both regions, with a surge in flu cases in the United Kingdom in the past week.
In addition, the emergence of…
Continue Reading
-

‘Exodus’ is a spiritual successor to ‘Mass Effect’ with a hard sci-fi edge. We spoke to the devs about time-dilation, human evolution, and honoring hard sci-fi (exclusive)
EXODUS – The Rise of Jun Aslan | Official Trailer – YouTube
Watch OnThe Game Awards 2025 was in full swing last night with sneak peeks, trailer reveals, and more geeky video games than you can shake a custom dual-shock controller at….
Continue Reading

